Palatin Technologies (PTN) Amortizatization of Intangibles (2013 - 2019)
Palatin Technologies' (PTN) quarterly Amortizatization of Intangibles came in at $438.0 in Q3 2019, down 98.14% YoY from $23581.0 in Q3 2018, and down 94.42% on a QoQ basis from $7850.0 in Q1 2019.
Palatin Technologies (PTN) Amortizatization of Intangibles (2013 - 2019) Analysis & Trends
Palatin Technologies (PTN) has 7 years of Amortizatization of Intangibles data on file, last reported at $438.0 in Q3 2019.
- Quarterly Amortizatization of Intangibles fell 98.14% year-over-year to $438.0 in Q3 2019, while the trailing twelve-month figure through Sep 2020 was $438.0 (down 99.08% YoY) and the FY2013 annual result came in at $1365.0, changed N/A from the prior year.
- Amortizatization of Intangibles declined to $438.0 in Q3 2019, from $7850.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $82998.0 in Q1 2016 to a low of -$93419.0 in Q2 2015.
- A 5-year average of $41192.9 and a median of $52054.0 in 2017 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2016 — Amortizatization of Intangibles gained 1.89% — and 2019, when it plunged 98.14%.
- Tracing PTN's Amortizatization of Intangibles over 5 years: stood at $80739.0 in 2015, then slipped by 2.84% to $78445.0 in 2016, then slumped by 38.9% to $47926.0 in 2017, then sank by 66.86% to $15881.0 in 2018, then plunged by 97.24% to $438.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $438.0 (Q3 2019), $7850.0 (Q1 2019), and $15881.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | 63,317.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 438.00 |
| Sep 30, 2019 | 438.00 |
| Mar 31, 2019 | 7,850.00 |
| Mar 31, 2019 | 7,850.00 |
| Dec 31, 2018 | 15,881.00 |
| Dec 31, 2018 | 15,881.00 |
| Sep 30, 2018 | 23,581.00 |
| Sep 30, 2018 | 23,581.00 |
| Mar 31, 2018 | 39,729.00 |
| Mar 31, 2018 | 39,729.00 |
| Dec 31, 2017 | 47,926.00 |
| Dec 31, 2017 | 47,926.00 |
| Sep 30, 2017 | 56,182.00 |
| Sep 30, 2017 | 56,182.00 |
| Mar 31, 2017 | 73,345.00 |
| Mar 31, 2017 | 73,345.00 |
| Dec 31, 2016 | 78,445.00 |
| Dec 31, 2016 | 78,445.00 |
| Sep 30, 2016 | 82,266.00 |
| Sep 30, 2016 | 82,266.00 |